YOU ARE HERE: LAT HomeCollectionsGlucose Levels

Glucose Levels

August 9, 1992
As an Hispanic who has been recently diagnosed with diabetes mellitus, I read your article ("Minority Groups at Risk of Diabetes," July 21) with interest. I am currently enrolled in a research study at Harbor-UCLA Medical Center, Division of Endocrinology and Metabolism, that is investigating the effects of the drug glipizide on the blood-glucose levels in minorities. Through education received here, I have learned that with proper diet, medication, exercise, constant personal monitoring of my blood-sugar levels, and most of all, attitude adjustment, I will live a productive life.
August 12, 1993 | Associated Press
Diabetics who have been barred from driving trucks or buses across state lines will be allowed to operate the vehicles if they meet stringent conditions, the federal government announced Wednesday. The Federal Highway Administration said insulin-using diabetics who qualify will be given waivers to drive the vehicles in interstate commerce for three years while the agency seeks to develop a permanent rule.
July 1, 1998
UCLA was awarded a $3.5-million grant Tuesday to study how the brain responds to traumatic injury. The five-year grant from the National Institutes of Neurological Disorders and Stroke will fund a collaborative study by the Division of Neurosurgery and the Department of Molecular and Medical Pharmacology. "There is a traumatic brain injury occurring once every 10 seconds in the United States," said Donald Becker, chief of neurosurgery.
March 14, 2006 | From the Associated Press
Abbott Laboratories said Monday that it had received approval from the Food and Drug Administration for a new blood glucose monitoring system -- an announcement that came as its stock rose to a six-month high. The go-ahead added to Abbott's momentum after the release of positive results from the first trial of its ZoMaxx device, a drug-coated stent intended to unclog arteries to the heart, Sunday at the American College of Cardiology's annual meeting in Atlanta.
January 8, 2014 | By Melissa Healy
The Food and Drug Administration on Wednesday approved U.S. marketing of the drug dapagliflozin, the second of a new class of medications that aim to improve glycemic control in patients with Type 2 diabetes. The drug will be marketed under the name Farxiga. Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, a drug that blocks the reabsorption of glucose by the kidney, increases the excretion of glucose in urine and lowers glucose levels in the blood. It will join -- and is likely to be prescribed in conjunction with -- a wide range of diabetes medications, including metformin, pioglitazone, glimepiride, sitagliptin and insulin.
September 22, 2011 | By Shari Roan, Los Angeles Times / For the Booster Shots blog
Liposuction patients are usually after one thing: a better-looking body. But a new study suggests the cosmetic procedure that removes fat from well-padded areas of the body may also reduce harmful fat circulating in the blood. Research to be presented Sunday at the annual meeting of the American Society of Plastic Surgeons in Denver was aimed at measuring triglyceride levels in 229 people having liposuction. In people with normal triglyceride levels, cosmetic surgery made no difference.
December 12, 2013 | By Melissa Rohlin
Last season, while Dwight Howard was recovering from back surgery, he also apparently was struggling with another problem -- sugar. After watching Howard play for the Lakers, Dr. Cate Shanahan was struck by what she saw.  "It looked like he was wearing oven mitts out there," Shanahan told . "It reminded me of patients who have pre-diabetes and neurological problems because of how sugar impacts the nervous system. That's where I became really concerned. " Shanahan contacted longtime Laker trainer Gary Vitti, and set up a meeting with the 28-year-old center.  She discovered that Howard's glucose readings were sky-high.
November 15, 2004 | Melissa Healy, Times Staff Writer
All right, it's not the fountain of youth. But a study published in the Nov. 10 issue of the Journal of the American Medical Assn. has found that DHEA, a hormone widely marketed as a nutritional supplement, decreases belly fat and improves the body's use of insulin among the elderly when taken daily for six months. Earlier studies have shown that DHEA supplementation led to improved bone density and an enhanced sense of well-being. "We were surprised that there was such an effect," said Dr.
June 24, 2011 | By Marissa Cevallos, HealthKey / For the Booster Shots blog
Weight-loss surgery can cure many obese people -- perhaps more than 60% of them -- of their diabetes, at least in the short term, suggests a new analysis of several studies. Though previous research had suggested that weight-loss surgery could reverse diabetes, researchers from the Netherlands have formalized the evidence a bit through a review of nine studies published in the June Archives of Surgery . Among the studies included in the analysis, 424 people with Type 2 diabetes underwent Roux-en-Y gastric bypass surgery, in which the surgeon creates a small pouch in the stomach that restricts food intake and bypasses part of the small intestines to cut down on absorption.
December 2, 2013 | By Melissa Healy
So your body mass index says you're obese, but you don't have "pre-diabetes" - a mix of factors such as hypertension, high cholesterol and high glucose levels that indicates you're on the road to metabolic illness. And you're thinking you've beaten the odds, right? Wait 10 years, a new study says. Odds are, you'll be proven wrong. New research finds that even when a person is "metabolically healthy," being obese raises his or her risk for cardiovascular disease and premature death.
Los Angeles Times Articles